BioNTech SE is 1.6x more valuable than EXELIXIS, INC. by market capitalization ($21.79 B vs $13.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXEL | BNTX |
|---|---|---|
| Market cap | $13.22 B | $21.79 B |
| US-listed rank | #789 | #587 |
| Revenue (latest FY) | $2.32B | - |
| Net income (latest FY) | $782.60M | - |
| Net margin | 33.7% | - |
| P/E (trailing FY) | 16.9 | - |
| SEC filings | 2,488 | 548 |
BioNTech SE is 1.6x more valuable than EXELIXIS, INC. by market capitalization ($21.79 B vs $13.22 B).
Full pages: EXELIXIS, INC. and BioNTech SE, or browse the full rankings.